Literature DB >> 11556167

[Changes in blood volume during acute normovolemic hemodilution with 5% albumin or 6% hydroxyethylstarch and intraoperative retransfusion].

M Rehm1, V H Orth, U Kreimeier, M Thiel, S Mayer, H Brechtelsbauer, U Finsterer.   

Abstract

QUESTION: What is the impact of acute preoperative normovolemic hemodilution (ANH) on blood volume, intravascular colloid, and loss of red cells in the perioperative period?
METHODS: In 20 patients undergoing radical hysterectomy, preoperative ANH was performed to a hematocrit of 22% using 5% albumin (albumin group; n = 10) or 6% hydroxyethylstarch solution (HES group; n = 10). Intraoperative retransfusion of ANH blood was started at a hematocrit of 18%. Plasma volume (indocyanine green-dilution technique), hematocrit, and plasma protein concentration were measured before and after ANH, before retransfusion, and postoperatively. Red cell volume (labelling erythrocytes with fluorescein) was determined before and after ANH and postoperatively. In the HES group hydroxyethylstarch concentrations were measured in plasma and urine.
RESULTS: After removal of about 1,500 ml of blood and replacement with 15% more colloid solution, the blood volume was maintained in both groups after ANH. After a mean blood loss of about 1,800 ml, an average of 150 ml of red cells were saved due to ANH in both groups.
CONCLUSIONS: Double label measurements of blood volume demonstrated that with the colloids used a surplus of 15% of colloid infusion in relation to blood removal was necessary to generate isovolemia after ANH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556167     DOI: 10.1007/s001010100165

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  12 in total

1.  [Perioperative fluid management: A relay race of knowledge].

Authors:  M Jacob; K Peter; M Rehm
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

Review 2.  [Determinants of insensible fluid loss. Perspiration, protein shift and endothelial glycocalyx].

Authors:  M Jacob; D Chappell; K Hofmann-Kiefer; P Conzen; K Peter; M Rehm
Journal:  Anaesthesist       Date:  2007-08       Impact factor: 1.041

Review 3.  [Expedition glycocalyx. A newly discovered "Great Barrier Reef"].

Authors:  D Chappell; M Jacob; B F Becker; K Hofmann-Kiefer; P Conzen; M Rehm
Journal:  Anaesthesist       Date:  2008-10       Impact factor: 1.041

Review 4.  [State of the art in fluid and volume therapy : A user-friendly staged concept].

Authors:  M Rehm; N Hulde; T Kammerer; A S Meidert; K Hofmann-Kiefer
Journal:  Anaesthesist       Date:  2017-03       Impact factor: 1.041

Review 5.  [Limited applications for hydroxyethyl starch : background and alternative concepts].

Authors:  M Rehm
Journal:  Anaesthesist       Date:  2013-08       Impact factor: 1.041

6.  State of the art in fluid and volume therapy : A user-friendly staged concept. English version.

Authors:  M Rehm; N Hulde; T Kammerer; A S Meidert; K Hofmann-Kiefer
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

Review 7.  [Fluid resuscitation in hemorrhage].

Authors:  M Roessler; K Bode; M Bauer
Journal:  Anaesthesist       Date:  2014-10       Impact factor: 1.041

8.  [Exact measurement of the volume effect of 6% hydoxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution].

Authors:  M Jacob; M Rehm; V Orth; M Lötsch; H Brechtelsbauer; E Weninger; U Finsterer
Journal:  Anaesthesist       Date:  2003-10       Impact factor: 1.041

9.  Perioperative fluid and volume management: physiological basis, tools and strategies.

Authors:  Mike S Strunden; Kai Heckel; Alwin E Goetz; Daniel A Reuter
Journal:  Ann Intensive Care       Date:  2011-03-21       Impact factor: 6.925

10.  The use of a volatile anesthetic regimen protects against acute normovolemic hemodilution induced myocardial depression in patients with coronary artery disease.

Authors:  Sratwadee Lorsomradee; Suraphong Lorsomradee
Journal:  Asian J Transfus Sci       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.